Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page presents an observational study comparing regorafenib and fruquintinib in patients with metastatic colorectal cancer after second-line therapy. It includes study eligibility, a recruiting location in Beijing, and measures of treatment failure, survival, and adverse events.
    Difference
    39%
    Check dated 2026-11-08T14:56:45.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-11-01T15:50:37.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” across NIH content. It appears above the existing 403 error page.
    Difference
    1%
    Check dated 2026-10-25T15:52:49.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T15:47:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T16:34:36.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error for the study entry, replacing the expected study content with an access-denied message. This reflects a permission issue rather than an update to the study information itself.
    Difference
    17%
    Check dated 2026-09-20T20:25:12.000Z thumbnail image

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.